H.R. 5509In committeeHealth care
Patients could appeal insurer step therapy rules within 72 hours
Data as of July 11, 2026
Employer health plans would have to let patients skip "step therapy" drug requirements under certain conditions and respond within 72 hours.50-second read · 4 questions answered below
Decoded
What does this do?
This bill sets rules for employer-sponsored health plans that require patients to try cheaper drugs before covering the one their doctor prescribed. Plans would need a formal process for patients or doctors to request an exception, with a response required within 72 hours, or 24 hours in urgent situations. Exceptions must be approved when prior drugs failed, are unsafe, or when delay could cause serious harm, and approved coverage must last at least one year.
Who does it affect?
This affects patients enrolled in employer-sponsored health insurance plans and the doctors who treat them. Health plans covered by this bill would also be required to report exception data annually to the federal government.
Why does it matter?
Without a required exception process, patients whose doctors prescribed a specific drug may face delays or denials getting that medication. This bill would create a legal requirement for plans to respond and decide within set time limits.
Where does it stand?
- Introduced
- House committee — You are here
- House vote
- Senate
- President's desk
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Safe Step Act
- Introduced:
- September 19, 2025
- Latest action:
- September 19, 2025
Referred to the House Committee on Education and Workforce.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.